XML 89 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Employee Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of nonvested share activity
The Company’s RSU, RSA and PSA activity and related information as of and for the three months ended March 31, 2020 were as follows (in millions, except per share amounts and years):
 
Outstanding RSUs, RSAs and PSAs
 
Number of Shares
 
Weighted Average
Grant-Date Fair
Value per Share
 
Weighted Average
Remaining
Contractual Term
(In Years)
 
Aggregate
Intrinsic
Value
Balance as of December 31, 2019
17.5

 
$
25.30

 
 
 
 
Granted(*)
2.6

 
22.80

 
 
 
 
Vested
(4.2
)
 
26.01

 
 
 
 
Canceled
(1.0
)
 
25.78

 
 
 
 
Balance as of March 31, 2020
14.9

 
$
24.62

 
1.3
 
$
284.5

________________________________
(*) 
Includes 1.4 million service-based, 0.8 million performance-based, and 0.4 million market-based RSUs. The number of shares subject to performance-based and market-based condition represents the aggregate maximum number of shares that may be issued pursuant to the award over its full term. The grant date fair value of RSUs and PSAs was reduced by the present value of dividends expected to be paid on the underlying shares of common stock during the requisite and derived service period as these awards are not entitled to receive dividends until vested.
Schedule of employee stock purchases through ESPP
The following table summarizes employee stock purchases through the ESPP (in millions, except per share amounts):
 
Three Months Ended March 31,
 
2020
 
2019
Shares purchased
1.4

 
1.2

Average exercise price per share
$
19.50

 
$
22.04


Schedule of employee service share-based compensation, allocation of recognized period costs
Share-based compensation expense associated with stock options, RSUs, RSAs, PSAs, and the ESPP was recorded in the following cost and expense categories in the Condensed Consolidated Statements of Operations (in millions):
 
Three Months Ended March 31,
 
2020
 
2019
Cost of revenues - Product
$
1.4

 
$
1.9

Cost of revenues - Service
4.2

 
4.5

Research and development
15.2

 
12.2

Sales and marketing
13.8

 
9.4

General and administrative
7.4

 
5.9

Total
$
42.0

 
$
33.9


Disclosure of share-based compensation arrangements by share-based payment award
The following table summarizes share-based compensation expense by award type (in millions):
 
Three Months Ended March 31,
 
2020
 
2019
Stock options
$
1.9

 
$
0.1

RSUs, RSAs, and PSAs
34.9

 
29.1

ESPP
5.2

 
4.7

Total
$
42.0

 
$
33.9